SCHEMBL2820813

SCHEMBL2820813

CC(C(N)=O)c1cccc2nc[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCL8 P10145 1/20 0.40
PARP1 P09874 6/20 0.37
PDPK1 O15530 1/20 0.34
CA12 O43570 1/20 0.34
ALOX15 P16050 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CA9 Q16790 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
HSP90AB1 P08238 1/20 0.33
FLT4 P35916 3/20 0.32
KDR P35968 1/20 0.32
EPHX1 P07099 1/20 0.32
GDA Q9Y2T3 1/20 0.32
CYP1A2 P05177 1/20 0.32
HTT P42858 1/20 0.32
PAK1 Q13153 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497541 0.86 CXCL8 (0.39) CXCL8PARP1PDPK1CA12ALOX15
SCHEMBL7036443 0.82 PARP1 (0.34) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL2817264 0.82 PARP1 (0.34) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL22559041 0.80 CYP1A2 (0.39) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL7727344 0.80 TAAR1 (0.40) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL2495510 0.78 PARP1 (0.34) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL2820806 0.77 PARP1 (0.56) CXCL8PARP1
SCHEMBL14477036 0.74 TSHR (0.42) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL663849 0.73 PARP1 (0.56) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL2496016 0.73 PARP1 (0.35) PARP1PDPK1CA12ALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010110686-A1 PYRIMIDINYL AND 1,3,5 TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY PATHWAY THERAPEUTICS LIMITED (NZ) 2010-09-30 WO disclosed